Usher Syndrome
Overview
Usher Syndrome is a condition with relevance to the neurodegenerative disease landscape. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.
Usher syndrome is a rare genetic disorder characterized by the combination of sensorineural hearing loss, progressive vision loss due to retinitis pigmentosa, and in some cases, vestibular dysfunction. It is the most common cause of deaf-blindness worldwide and represents a significant challenge for affected individuals and their families[@boughman1983].
Epidemiology
Usher syndrome affects approximately 1 in 6,000 to 1 in 10,000 people worldwide, making it one of the most prevalent autosomal recessive disorders causing combined hearing and vision loss[@kimberling2015]. The syndrome accounts for approximately 3-6% of all childhood deafness and about 50% of all cases of deaf-blindness in adults[@rosenberg1997]. There are three main clinical subtypes (USH1, USH2, and USH3), with USH2 being the most common, representing approximately 50-60% of all cases[@milln2011].
Genetics
Usher syndrome is inherited in an autosomal recessive pattern. To date, at least 26 genes have been implicated in Usher syndrome and related phenotypes. The most common genes associated with each subtype include[@toms2020]:
...Usher Syndrome
Overview
Usher Syndrome is a condition with relevance to the neurodegenerative disease landscape. This page covers its molecular basis, clinical features, genetic associations, and connections to broader neurodegeneration research.
Usher syndrome is a rare genetic disorder characterized by the combination of sensorineural hearing loss, progressive vision loss due to retinitis pigmentosa, and in some cases, vestibular dysfunction. It is the most common cause of deaf-blindness worldwide and represents a significant challenge for affected individuals and their families[@boughman1983].
Epidemiology
Usher syndrome affects approximately 1 in 6,000 to 1 in 10,000 people worldwide, making it one of the most prevalent autosomal recessive disorders causing combined hearing and vision loss[@kimberling2015]. The syndrome accounts for approximately 3-6% of all childhood deafness and about 50% of all cases of deaf-blindness in adults[@rosenberg1997]. There are three main clinical subtypes (USH1, USH2, and USH3), with USH2 being the most common, representing approximately 50-60% of all cases[@milln2011].
Genetics
Usher syndrome is inherited in an autosomal recessive pattern. To date, at least 26 genes have been implicated in Usher syndrome and related phenotypes. The most common genes associated with each subtype include[@toms2020]:
| Subtype | Gene(s) | Protein Function |
|---------|----------|-------------------|
| USH1B | MYO7A | Myosin VIIA - critical for hair cell stereocilia organization |
| USH1C | USH1C (harmonin) | Scaffold protein in hair cell stereocilia |
| USH1D | CDH23 | Cadherin 23, cell adhesion in stereocilia |
| USH1F | PCDH15 | Protocadherin 15, tip link formation |
| USH1G | USH1G (sans) | Scaffold protein for protein complexes |
| USH1H | CIB2 | Calcium and integrin binding protein |
| USH2A | USH2A (usherin) | Receptor complex in photoreceptors and inner ear |
| USH2C | VLGR1 | Very large G-protein coupled receptor |
| USH2D | WHRN (whirlin) | Scaffold protein in stereocilia |
| USH3A | CLRN1 | Clarin-1, synaptic ribbon function |
| USH3B | HARS1 | Histidyl-tRNA synthetase |
The USH2A gene is the most frequently mutated, accounting for approximately 30-40% of all Usher syndrome cases[@kremer2006]. Mutations in this gene cause USH2, the most common subtype.
Pathophysiology
Inner Ear (Cochlear) Pathology
The hearing loss in Usher syndrome results from degeneration of the sensory hair cells in the cochlea. In USH1 subtypes, there is typically profound congenital deafness due to complete loss of hair cells. In USH2, the hearing loss is usually moderate to severe and may be progressive[@sadegi2020].
The proteins encoded by Usher syndrome genes form a complex network localized to the stereocilia of hair cells, where they are essential for maintaining the structural integrity and function of these mechanosensory organelles. Mutations disrupt the development and maintenance of hair bundles, leading to hair cell degeneration[@richardson2014].
Retinal Pathology
The vision loss in Usher syndrome results from retinitis pigmentosa (RP), a progressive degeneration of the photoreceptor cells in the retina. The disease typically begins with night blindness and peripheral vision loss, progressing to tunnel vision and eventually central vision loss[@hartel2021].
The usherin protein (encoded by USH2A) is localized to the photoreceptor cell synapses and basal bodies, where it plays critical roles in phototransduction and photoreceptor maintenance. Mutations lead to progressive photoreceptor degeneration[@liu2021].
Vestibular Dysfunction
Some subtypes of Usher syndrome (particularly USH1) are associated with vestibular dysfunction due to abnormal development of the vestibular hair cells. This can lead to balance problems and delayed motor development in children[@malmstrom2022].
Clinical Features
Usher Syndrome Type 1 (USH1)
- Profound congenital sensorineural hearing loss
- Retinitis pigmentosa presenting in early childhood (typically before age 10)
- Severe vestibular dysfunction (balance problems) from birth
- Common genes: MYO7A (USH1B), CDH23 (USH1D), PCDH15 (USH1F)
Usher Syndrome Type 2 (USH2)
- Moderate to severe hearing loss (present from birth)
- Retinitis pigmentosa with later onset (typically adolescence to early adulthood)
- Normal vestibular function
- Common genes: USH2A (most common), VLGR1, WHRN
Usher Syndrome Type 3 (USH3)
- Progressive hearing loss (may have normal hearing at birth)
- Progressive retinitis pigmentosa (variable age of onset)
- Variable vestibular dysfunction
- Common genes: CLRN1, HARS1
Diagnosis
Clinical Diagnosis
The diagnosis of Usher syndrome is based on clinical findings including[@cremers2007]:
Audiological evaluation: Pure tone audiometry and auditory brainstem responses (ABR) to characterize the type and degree of hearing loss
Ophthalmological examination:
- Visual field testing
- Electroretinography (ERG) - typically shows reduced or absent responses
- Optical coherence tomography (OCT) to assess retinal structure
- Fundus autofluorescence imaging
3.
Vestibular testing: Caloric testing and rotatory chair testing to assess vestibular function
Genetic testing: Molecular genetic testing (gene panel or exome sequencing) to confirm the diagnosis and identify the specific gene mutationNewborn Screening
Newborn hearing screening can identify infants with congenital hearing loss, allowing for early referral for ophthalmological evaluation and genetic testing to diagnose Usher syndrome before the onset of visual symptoms[@loundon2020].
Management
There is currently no cure for Usher syndrome, but management strategies can help maintain function and quality of life[@rohl2023]:
Hearing Management
- Hearing aids: Amplification devices for those with residual hearing
- Cochlear implants: For individuals with profound hearing loss, cochlear implantation can provide significant benefit
- Sign language and visual communication: Early intervention with sign language and visual supports
- Assistive listening devices: FM systems, loop systems, and other assistive technologies
Vision Management
- Low vision aids: Magnifiers, specialized lighting, and electronic devices
- Orientation and mobility training: White cane training and orientation and mobility (O&M) specialists
- Genetic counseling: For family planning and understanding recurrence risks
- Regular ophthalmological monitoring: Annual eye exams to monitor disease progression
Emerging Therapies
Several therapeutic approaches are under investigation[@zallocchi2021]:
Gene therapy: Clinical trials are ongoing for USH1B (MYO7A) and USH2A (USH2A) using AAV vectors to deliver functional copies of the defective genes
Retinal prostheses: The Argus II retinal prosthesis has been approved for individuals with advanced RP
Pharmacological approaches: Neuroprotective agents, antioxidant therapies, and compounds targeting specific pathological pathways
Stem cell therapies: Research is ongoing into retinal pigment epithelium and photoreceptor cell transplantationPrognosis
The prognosis for individuals with Usher syndrome varies by subtype:
- USH1: Most severe phenotype; individuals typically have profound deafness from birth and develop RP in early childhood. Balance problems are present from infancy.
- USH2: Most common form; individuals usually have moderate hearing loss and develop RP in adolescence or early adulthood. Balance is typically normal.
- USH3: Highly variable; hearing loss and RP may progress at different rates. Some individuals maintain useful vision and hearing into adulthood.
Early diagnosis and intervention are critical for optimizing functional outcomes and quality of life. With appropriate support, individuals with Usher syndrome can achieve educational and professional goals and maintain independence[@damm2019].
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
Recent Research (2024-2026)
Recent research on Usher Syndrome includes:
- 2024: [Title](https://pubmed.ncbi.nlm.nih.gov/XXXXX/) - Description
References
[Boughman JA, Vernon M, Shaver KA, Usher syndrome: definition and estimation of prevalence from two high-risk populations (1983)](https://pubmed.ncbi.nlm.nih.gov/6885965/)
[Kimberling WJ, Hildebrand MS, Shearer AE, et al, Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of newborns (2015)](https://pubmed.ncbi.nlm.nih.gov/25851678/)
[Rosenberg T, Haim M, Hauch AM, Parving A, The prevalence of Usher syndrome and other retinal dystrophy-hearing impairment associations (1997)](https://pubmed.ncbi.nlm.nih.gov/9185148/)
[Millán JM, Aller E, Jaijo T, Blanco-Kelly F, Giménez-Pardo A, Ayuso C, An update on the genetics of Usher syndrome (2011)](https://pubmed.ncbi.nlm.nih.gov/21234346/)
[Toms M, Pagarkar W, Moore A, Usher syndrome: clinical features, molecular genetics and advancing gene therapies (2020)](https://pubmed.ncbi.nlm.nih.gov/33132961/)
[Kremer H, van Wijk E, Märker T, et al, USH2A gene: mutation spectrum and database (2006)](https://pubmed.ncbi.nlm.nih.gov/16941493/)
[Sadegi M, Koohbanani SS, Rajati M, Ghadiri G, Auditory phenotype in Usher syndrome: a comprehensive review (2020)](https://pubmed.ncbi.nlm.nih.gov/32957069/)
[Richardson KK, Wang L, Lin JH, Usher syndrome: bridging the gap between gene discovery and understanding of hair cell dysfunction (2014)](https://pubmed.ncbi.nlm.nih.gov/24752745/)
[Hartel BP, van Nierop JWI, Huigen M, et al, Usher syndrome: a review of the clinical phenotype and underlying genetics (2021)](https://pubmed.ncbi.nlm.nih.gov/33752684/)
[Liu X, Vashist S, Bhattacharya SK, Molecular pathology of USH2A: a review (2021)](https://doi.org/10.1016/j.exer.2021.108579)
[Malmstrom H, Grondahl J, Grondahl-Norin C, Vestibular function in Usher syndrome: a systematic review (2022)](https://pubmed.ncbi.nlm.nih.gov/35617982/)
[Cremers FP, Kimberling WJ, Külm M, et al, Classification of Usher syndrome: a practical approach (2007)](https://pubmed.ncbi.nlm.nih.gov/17851909/)
[Loundon N, Marcolla A, Roux I, et al, Newborn hearing screening and Usher syndrome (2020)](https://pubmed.ncbi.nlm.nih.gov/32650914/)
[Rohl S, Pang J, Zhang Y, et al, Management of Usher syndrome: current practices and future directions (2023)](https://doi.org/10.1038/s41572-023-00437-4)
[Zallocchi M, Mehta V, Acland GM, et al, Emerging therapies for Usher syndrome type 1B: from gene therapy to retinal prosthetics (2021)](https://pubmed.ncbi.nlm.nih.gov/34282453/)
[Damm L, Le S, N Courtney M, et al, Psychosocial aspects of Usher syndrome: a review and recommendations (2019)](https://doi.org/10.1177/0145482X19893074)
Genetic Variants
Gene: WHRN
| Variant | Clinical Significance | Conditions |
|---|---|---|
| NM_015404.4(WHRN):c.1866G>A (p.Ser622=) | Likely benign | not provided |
| NM_015404.4(WHRN):c.921T>G (p.Thr307=) | Likely benign | not provided |
| NM_015404.4(WHRN):c.2151A>G (p.Thr717=) | Likely benign | not provided |
| NM_015404.4(WHRN):c.230C>G (p.Thr77Ser) | Likely benign | not provided |
| NM_015404.4(WHRN):c.1838_1839inv (p.Met613Thr) | Likely benign | not provided |